HQY.NASDAQHealthequity, INC

Form 4: HealthEquity EVP, CHIEF TECHNOLOGY OFFICER Rosner Elimelech Sells Shares

Sentiment:

SEC Form 4 Filing

📋All filings for Healthequity, INC
🔒Login to Follow

Elimelech Rosner, EVP, CHIEF TECHNOLOGY OFFICER of HealthEquity, Inc., sold 12,296 shares of common stock at a weighted average price of $77.0242 on September 6, 2024.

Summary

  • On September 6, 2024, Elimelech Rosner, the EVP, CHIEF TECHNOLOGY OFFICER of HealthEquity, Inc. (HQY), sold 12,296 shares of the company's common stock.
  • The sale was executed at a weighted average price of $77.0242 per share.
  • Following the transaction, Rosner directly owns 62,520 shares of HealthEquity, Inc.
  • The shares were sold in multiple transactions at prices ranging from $77.00 to $77.20 inclusive.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by an executive. It doesn't inherently convey positive or negative sentiment, but the market may interpret the sale as a neutral to slightly negative signal.

Industry Context

This Form 4 filing indicates insider trading activity, which is a common occurrence. Investors often monitor these filings to gain insights into management's perspective on the company's stock and future prospects.

Stakeholder Impact

  • Shareholders may react to the insider selling activity, potentially influencing the stock price.

Key Dates

DateDescription
07/07/2023Date of Power of Attorney filing by Mr. Rosner with the U.S. Securities and Exchange Commission.
09/06/2024Date of the transaction where Elimelech Rosner sold shares of HealthEquity, Inc.
09/10/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.